What are the mechanisms associated with post-ivermectin serious adverse events?

dc.contributor.authorMichel Boussinesq
dc.contributor.authorJoseph Kamgno
dc.contributor.authorSébastien D. S. Pion
dc.contributor.authorJacques Gardon
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:15:10Z
dc.date.available2026-03-22T21:15:10Z
dc.date.issued2006
dc.descriptionCitaciones: 34
dc.identifier.doi10.1016/j.pt.2006.04.006
dc.identifier.urihttps://doi.org/10.1016/j.pt.2006.04.006
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/86838
dc.language.isoen
dc.publisherElsevier BV
dc.relation.ispartofTrends in Parasitology
dc.sourceInstitut de Recherche pour le Développement
dc.subjectIvermectin
dc.subjectOnchocerciasis
dc.subjectConfusion
dc.subjectAdverse effect
dc.subjectWonder
dc.subjectMedicine
dc.subjectAntiparasitic agent
dc.subjectIntensive care medicine
dc.subjectPsychiatry
dc.subjectPsychology
dc.titleWhat are the mechanisms associated with post-ivermectin serious adverse events?
dc.typeletter

Files